Suntrust Banks’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $716K | Sell |
10,624
-3,527
| -25% | -$238K | ﹤0.01% | 835 |
|
|
2019
Q2 | $1.21M | Sell |
14,151
-1,685
| -11% | -$144K | 0.01% | 712 |
|
|
2019
Q1 | $1.41M | Buy |
15,836
+1,123
| +8% | +$99.7K | 0.01% | 671 |
|
|
2018
Q4 | $1.25M | Buy |
14,713
+806
| +6% | +$68.6K | 0.01% | 647 |
|
|
2018
Q3 | $1.35M | Buy |
13,907
+3,800
| +38% | +$369K | 0.01% | 667 |
|
|
2018
Q2 | $953K | Buy |
10,107
+1,724
| +21% | +$163K | 0.01% | 747 |
|
|
2018
Q1 | $680K | Buy |
8,383
+3,182
| +61% | +$258K | ﹤0.01% | 808 |
|
|
2017
Q4 | $464K | Sell |
5,201
-22
| -0.4% | -$1.96K | ﹤0.01% | 886 |
|
|
2017
Q3 | $486K | Buy |
5,223
+1,500
| +40% | +$140K | ﹤0.01% | 881 |
|
|
2017
Q2 | $338K | Buy |
3,723
+868
| +30% | +$78.8K | ﹤0.01% | 994 |
|
|
2017
Q1 | $251K | Buy |
+2,855
| New | +$251K | ﹤0.01% | 1097 |
|
|
2016
Q3 | – | Sell |
-7,153
| Closed | -$555K | – | 1540 |
|
|
2016
Q2 | $555K | Sell |
7,153
-2,111
| -23% | -$164K | ﹤0.01% | 918 |
|
|
2016
Q1 | $763K | Buy |
9,264
+94
| +1% | +$7.74K | ﹤0.01% | 785 |
|
|
2015
Q4 | $958K | Buy |
+9,170
| New | +$958K | 0.01% | 701 |
|
|
2015
Q1 | – | Sell |
-3,138
| Closed | -$283K | – | 1226 |
|
|
2014
Q4 | $283K | Sell |
3,138
-16,471
| -84% | -$1.49M | ﹤0.01% | 1009 |
|
|
2014
Q3 | $1.41M | Sell |
19,609
-1,770
| -8% | -$128K | 0.01% | 532 |
|
|
2014
Q2 | $1.33M | Buy |
21,379
+4,474
| +26% | +$278K | 0.01% | 588 |
|
|
2014
Q1 | $1.15M | Sell |
16,905
-493
| -3% | -$33.6K | ﹤0.01% | 896 |
|
|
2013
Q4 | $1.22M | Sell |
17,398
-2,523
| -13% | -$177K | ﹤0.01% | 839 |
|
|
2013
Q3 | $1.44M | Sell |
19,921
-3,034
| -13% | -$219K | 0.01% | 757 |
|
|
2013
Q2 | $1.28M | Buy |
+22,955
| New | +$1.28M | 0.01% | 750 |
|